Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 11, 2009, Pages 1741-1746

  Martens, Daniëlle H J ^a   Rake, Jan Peter ^b   Navis, Gerjan ^a   Fidler, Vaclav ^a   Van Dael, Catharina M L ^a   Smit, G Peter A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME INHIBITION; FEMALE; GLOMERULUS FILTRATION RATE; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; INFANT; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; METABOLIC REGULATION; MICROALBUMINURIA; PROTEINURIA; RENAL PROTECTION;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; IODINE RADIOISOTOPES; IODOHIPPURIC ACID; IOTHALAMIC ACID; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; REGRESSION ANALYSIS; RENAL CIRCULATION; SEVERITY OF ILLNESS INDEX;

EID: 73449099600     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00050109     Document Type: Article

References (22)

1. Scriver C, Childs B: The Metabolic and Molecular Bases of Inherited Disease, 8th Ed., New York, McGraw-Hill, Medical Publishing Division, 2005
2. Fernandes J, Saudubray JM, Berghe GVD: Inborn Metabolic Diseases: Diagnosis and Treatment, 4th Ed., Berlin, Springer, 2006
3. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP: Glycogen storage disease type I: Diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161[Suppl 1]: S20-S34, 2002
4. Restaino I, Kaplan BS, Stanley C, Baker L: Nephrolithiasis, hypocitraturia, and a distal renal tubular acidification defect in type 1 glycogen storage disease. J Pediatr 122: 392-396, 1993
5. Weinstein DA, Somers MJ, Wolfsdorf JI: Decreased urinary citrate excretion in type 1a glycogen storage disease. J Pediatr 138: 378-382, 2001
6. Reitsma-Bierens WC: Renal complications in glycogen storage disease type I. Eur J Pediatr 152[Suppl 1]: S60-S62, 1993
7. Lee PJ, Dalton RN, Shah V, Hindmarsh PC, Leonard JV: Glomerular and tubular function in glycogen storage disease. Pediatr Nephrol 9: 705-710, 1995
8. Lee PJ, Leonard JV: The hepatic glycogen storage diseases: Problems beyond childhood. J Inherit Metab Dis 18: 462-472, 1995
9. Chen YT: Type I glycogen storage disease: Kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 5: 71-76, 1991
10. Baker L, Dahlem S, Goldfarb S, Kern EF, Stanley CA, Egler J, Olshan JS, Heyman S: Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 35: 1345-1350, 1989
11. Chen YT, Coleman RA, Scheinman JI, Kolbeck PC, Sidbury JB: Renal disease in type I glycogen storage disease. N Engl J Med 318: 7-11, 1988
12. Mundy HR, Lee PJ: Glycogenosis type I and diabetes mellitus: A common mechanism for renal dysfunction? Med Hypotheses 59: 110-114, 2002
13. Strippoli GF, Craig MC, Schena FP, Craig JC: Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J Am Soc Nephrol 17: S153-S155, 2006
14. Ibrahim HA, Vora JP: Diabetic nephropathy. Baillieres Best Pract Res Clin Endocrinol Metab 13: 239-264, 1999
15. Melis D, Parenti G, Gatti R, Casa RD, Parini R, Riva E, Burlina AB, Vici CD, Di RM, Furlan F, Torcoletti M, Papadia F, Donati A, Benigno V, Andria G: Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: A multicentre retrospective study. Clin Endocrinol (Oxf) 63: 19-25, 2005
16. Apperloo AJ, de Zeeuw D, Donker AJ, de Jong PE: Precision of glomerular filtration rate determinations for longterm slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol 7: 567-572, 1996
17. Piepsz A, Tondeur M, Ham H: Revisiting normal (51) Crethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging 33: 1477-1482, 2006
18. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 98:649-658, 1996
19. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP: Guidelines for management of glycogen storage disease type I-European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161[Suppl 1]: S112-S119, 2002
20. Obara K, Saito T, Sato H, Ogawa M, Igarashi Y, Yoshinaga K: Renal histology in two adult patients with type I glycogen storage disease. Clin Nephrol 39: 59-64, 1993
21. Verani R, Bernstein J: Renal glomerular and tubular abnormalities in glycogen storage disease type I. Arch Pathol Lab Med 112: 271-274, 1988
22. Ubels FL, Rake JP, Slaets JP, Smit GP, Smit AJ: Is glycogen storage disease 1a associated with atherosclerosis? Eur J Pediatr 161[Suppl 1]: S62-S64, 2002